Considering individual PTH may dramatically change over the course due to MBD progression, using average PTH levels of the whole dialysis vintage in a retrospective cohort with patients of highly-varied length of follow-up might contribute to the bias. This evidence concerns the gene PTH and Marchiafava-Bignami disease.